You are here: vision-research.eu » Vision Research » Vision in the European Focus

Vision in the European Focus

Bioactive site of vasoinhibin identified: possible application as a drug for cancer and retinal diseases

Researchers from the Institute of Neurobiology at the National University of Mexico in Querétaro and the Institute of Clinical Chemistry at Paracelsus Medical Private University in Nuremberg identified the bioactive site of vasoinhibin, a natural protein that inhibits the growth of new blood...
» Bioactive site of vasoinhibin identified: possible application as a drug for cancer and retinal diseases

International Forum for Exchange

70 years ago, the founders had a dream – and that dream endures in the scientists and Nobel Laureates of the future.
» International Forum for Exchange

Restoration of night vision in adult mice

Complete congenital night blindness (CCNCS) is an incurable hereditary disease and a group of rare, clinically and genetically heterogeneous retinal disorders.
» Restoration of night vision in adult mice

Eye2Gene wins Artificial Intelligence in Health and Care Award

Eye2Gene is a web tool devised by University College London Moorfields Ophthalmic Reading Centre for genetic prediction of inherited retinal disease using machine learning.
» Eye2Gene wins Artificial Intelligence in Health and Care Award

Picky neurons

The visual thalamus is classically known to relay visual stimuli coming from the retina to the cerebral cortex. Researchers from the Max Planck Institute of Neurobiology now show that although neurons in the mouse visual thalamus connect to both eyes, they establish strong functional connections...
» Picky neurons

Institute of Ophthalmology (IOO) Day 2021 at University College London

A yearly celebration of the people and the initiatives at our institute.
» Institute of Ophthalmology (IOO) Day 2021 at University College London

New antibody therapy may reverse diabetic retinopathy and other eye conditions

The life-saving diabetic medication insulin, developed at the University of Toronto 100 years ago, was the first biologic therapy - a protein to treat disease. A century later, a new biologic therapy also developed by researchers at U of T has potential to reverse a common complication of diabetes.
» New antibody therapy may reverse diabetic retinopathy and other eye conditions

Sharp vision with exchanged eye lens: LZH works on improved lens refilling

In eye surgery for cataract, the lens refilling method could allow to maintain or restore the lens's accommodation of the lens, i.e. the ability to adjust its refractive power flexibly. So far, however, this method has not yet been clinically successful. The Laser Zentrum Hannover e.V. (LZH) is now...
» Sharp vision with exchanged eye lens: LZH works on improved lens refilling

New analysis tool of microscopic images with Deepflash

Information technology can make life easier in many areas – including research. In medicine, for example, it is still standard practice to evaluate microscopy images of tissue sections by hand. Microscopic images of tissue sections can now be analyzed much more easily – with an innovative digital...
» New analysis tool of microscopic images with Deepflash

Development of Artificial Intelligence for the Management of Retinal Diseases

New Christian Doppler Laboratory opened at MedUni Vienna
» Development of Artificial Intelligence for the Management of Retinal Diseases